✦ LIBER ✦

The Efficacy and Safety of Switching to Ziprasidone from Olanzapine in Patients with Bipolar I Disorder: An 8-Week, Multicenter, Open-Label Study

✍ Scribed by Lee, Hwang-Bin; Yoon, Bo-Hyun; Kwon, Young-Joon; Woo, Young Sup; Lee, Jung-Goo; Kim, Moon-Doo; Bahk, Won-Myong

Book ID: 125386751
Publisher: Springer International Publishing AG
Year: 2013
Tongue: English
Weight: 381 KB
Volume: 33
Category: Article
ISSN: 1179-1918
DOI: 10.1007/s40261-013-0120-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.2.e.023 Switching from olanzapine to z

P.2.e.023 Switching from olanzapine to ziprasidone in patients with bipolar I disorder: an 8-week, multicenter, open-label study

✍ B. Yoon; M. Kim; H. Lee; Y. Kwon; W. Bahk 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Switching from olanzapine to ziprasidone

Switching from olanzapine to ziprasidone in patients with bipolar disorder: An 8-weeks, multi-center open-label trial

✍ B. Yoon⁎; W. Bahk; H. Lee; Y. Kwon; Y. Woo; M. Kim 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 50 KB

P.2.e.018 Switching from olanzapine to z

P.2.e.018 Switching from olanzapine to ziprasidone in patients with bipolar disorder: a 24-weeks, multi-center open-label trial

✍ B. Yoon; W. Bahk; K. Min; D. Jon; Y. Shin; S. Lee 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

P.2.e.023 Switching from olanzapine to z

P.2.e.023 Switching from olanzapine to ziprasidone in patients with bipolar disorder: a 24-weeks, multi-center open-label trial

✍ B. Yoon; W. Bahk; H. Lee; Y. Woo; Y. Kwon; A. Bae; M. KIm 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 45 KB

EFFICACY AND TOLERABILITY OF SWITCHING F

EFFICACY AND TOLERABILITY OF SWITCHING FROM OLANZAPINE, RISPERIDONE, AND HALOPERIDOL TO ZIPRASIDONE IN PATIENTS WITH SCHIZOPHRENIA: AN INTERNATIONAL MULTICENTER STUDY

✍ Onur Karayal; Koksal Alptekin; Wing Lowe; Jamal Hafez; Shlomo Brook; Cengiz Akka 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Olanzapine monotherapy for acute depress

Olanzapine monotherapy for acute depression in patients with bipolar I or II disorder: results of an 8-week open label trial

✍ William V. Bobo; Richard A. Epstein; Richard C. Shelton 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Abstract We evaluated the efficacy, tolerability, and safety of olanzapine monotherapy in 20 adult patients with bipolar I or II disorder, depressed phase. Patients received open‐label olanzapine monotherapy (mean modal dose, 15 mg/day) for 8 weeks. Assessments of psychopathology (Montgomery–Asb